SCHEMBL2775429

SCHEMBL2775429

CC(C)(C)c1cc(/C=N/O)c(O)c(C(C)(C)C)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.58
▸ SMN1; SMN2 Q16637 4/20 0.57
▸ ALOX12 P18054 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ ALOX5 P09917 4/20 0.53
▸ PTGS2 P35354 4/20 0.53
▸ ALDH1A1 P00352 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ CA2 P00918 2/20 0.41
▸ CA1 P00915 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ POLB P06746 1/20 0.39
▸ TYR P14679 1/20 0.39
▸ HIF1A Q16665 5/20 0.39
▸ CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2775430 1.00 HTT (0.58) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL11521296 1.00 HTT (0.58) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL11748400 0.88 SMN1; SMN2 (0.53) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL16210516 0.86 ALOX5 (0.53) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL16210517 0.86 ALOX5 (0.53) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL19320482 0.86 ALOX5 (0.53) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL17511100 0.84 ALOX5 (0.52) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL20835869 0.84 ALOX5 (0.52) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL6118350 0.84 ALOX5 (0.52) HTTSMN1; SMN2ALOX12MAPTALOX5
SCHEMBL13470911 0.84 ALOX5 (0.52) HTTSMN1; SMN2ALOX12MAPTALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696932-B2 Cleaning composition FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2020-06-30 — — US disclosed
US-10345707-B2 Stripping process FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2019-07-09 — — US disclosed
US-20190016999-A1 CLEANING COMPOSITION FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2019-01-17 — — US disclosed
US-20180136563-A1 Stripping Process FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2018-05-17 — — US disclosed
US-20180136563-A1 Stripping Process FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2018-05-17 — — US disclosed
US-20170255100-A1 DRY FILM STRUCTURE FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2017-09-07 — — US disclosed
US-20170255100-A1 DRY FILM STRUCTURE FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2017-09-07 — — US disclosed
WO-2017023677-A1 CLEANING COMPOSITION FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2017-02-09 — — WO disclosed
US-7705157-B2 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts SYMYX SOLUTIONS, INC. (US) 2010-04-27 — — US disclosed
US-7705157-B2 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts SYMYX SOLUTIONS, INC. (US) 2010-04-27 — — US disclosed
US-7705157-B2 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts SYMYX SOLUTIONS, INC. (US) 2010-04-27 — — US disclosed
US-20100048841-A1 PHENOL-HETEROCYCLIC LIGANDS, METAL COMPLEXES, AND THEIR USES AS CATALYSTS SYMYX SOLUTIONS, INC. (US) 2010-02-25 — — US disclosed
US-20100048841-A1 PHENOL-HETEROCYCLIC LIGANDS, METAL COMPLEXES, AND THEIR USES AS CATALYSTS SYMYX SOLUTIONS, INC. (US) 2010-02-25 — — US disclosed
US-20100048841-A1 PHENOL-HETEROCYCLIC LIGANDS, METAL COMPLEXES, AND THEIR USES AS CATALYSTS SYMYX SOLUTIONS, INC. (US) 2010-02-25 — — US disclosed
WO-2006066126-A2 PHENOL-HETEROCYCLIC LIGANDS, METAL COMPLEXES, AND THEIR USES AS CATALYSTS SYMYX TECHNOLOGIES, INC. (US) 2006-06-22 — — WO disclosed
US-20060135713-A1 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts FREESLATE, INC. 2006-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135713-A1 Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts HPD, MYB, PCNA HTT 1882/4885SMN1; SMN2 3939/4885ALOX12 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback